There are a number of lipophilic cations that can be
chosen; the
triphenylphosphonium (TPP) ion is particularly unique for mitochondrion
targeting, mainly due to its simplicity in structure and ease to be
linked to the target molecules. In this work, mitochondrion-targeted
AB3-type novel phthalocyanine and porphyrin photosensitizers
(PSs) were synthesized and their photophysical photochemical properties
were defined. Fluorescence quantum yields (ΦF) are
0.009, 0.14, 0.13, and 0.13, and the singlet-oxygen quantum yields
(ΦΔ) are 0.27, 0.75, 0.57, and 0.58 for LuPcPox(OAc), AB
3
TPP-Pc, AB
3
TPP-Por-C4, and AB
3
TPP-Por-C6, respectively. To evaluate the photodynamic efficacy of the TPP-conjugated
PS cell viabilities of A549 and BEAS-2B lung cells were comparatively
measured and IC-50 values were determined. AB
3
TPP-Por-C4, AB
3
TPP-Por-C6, and AB
3
TPP-Pc compounds compared to the reference
molecules ZnPc and H
2
TPP were found to be highly cytotoxic (sub-micromolar
concentration) under the light. LuPcPox(OAc) is the most
effective molecule regarding cell killing (the activity). The cell
killing of the TPP-conjugated porphyrin derivatives exhibits a similar
response compared to LuPcPox(OAc) when the light absorbing
factor of the PS is normalized at 660 nm: TPP-conjugated porphyrins
absorb less light (lower extinction coefficient) but produce more
radical species (higher singlet-oxygen quantum yield) and therefore
effectively kill the cells. The singlet oxygen-producing capacity
of AB
3
TPP-Pc is
almost 3 times higher compared to LuPcPox(OAc) and 50%
more efficient with respect to ZnPc, suggesting that TPP-conjugated
phthalocyanine may serve as a good photosensitizer for photodynamic
therapy (PDT). The high singlet oxygen generation capacity of these
novel TPP-conjugated porphyrin and phthalocyanine PS suggests that
they might be useful for PDT requiring lower photosensitizer concentration
and reduced energy deposited through less light exposure.